Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational, Multicentre Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China

NCT06422663 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06422663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06422663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational, Multicentre Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 22, 2024
Completion date
March 13, 2025
Enrollment
500 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

moderate-to-severe asthma